Tag Archive for: Obesity

Atrogi announces Cell paper highlighting transformative potential of muscle-targeted therapy in metabolic disease

/in

Atrogi’s breakthrough discovery enables chronic use of next-generation, highly selective β2-agonists for the first time in metabolic disease First-in-class oral therapy ATR-258 mimics the effects of exercise – driving fat loss, increasing muscle, and improving metabolism – with broad potential in obesity, diabetes, and age-related muscle loss ATR-258 is set to enter Phase 2 trials […]

Read more

Hot topic: What if weight loss drugs are just the first longevity game-changers?

/in

Back in mid-January Optimum’s Hot Topics column took a look at life expectancy data and asked the rather depressing question: “Will you live longer than your parents – or not?”  Why so downbeat? Because besides stalling life expectancy figures, a slew of other data also seemed to hint that longevity might have peaked: steadily growing […]

Read more

Hot topic: JPM shines bright amid the January gloom

/in

2025 has already begun with drama in the U.S., as Los Angeles recovers from deadly wildfires and Donald Trump is sworn in for his second presidency. And so it was that the mood going into the annual JP Morgan Healthcare Conference was clouded by uncertainty. With its timing in January, JPM is often seen as […]

Read more

Experienced Industry Leader Dr. Joerg Moeller Appointed as Chief Executive Officer of Antag Therapeutics

/in

Former Head of Global R&D at Bayer AG and an exceptional leader with a wealth of experience across biopharma Pivotal time of transition as the company prepares to start clinical development of its first-in-class lead candidate, AT-7687 in obesity AT-7687 offers a new mechanism of action, to set a new standard in obesity management Copenhagen, […]

Read more

Antag Therapeutics Announces €80 Million Series A Financing

/in

Antag Therapeutics, a next-generation biopharmaceutical company pioneering novel treatments for obesity, today announced the closing of an €80 million Series A financing. The round was led by Versant Ventures, with participation from Novo Holdings, SR One, Dawn Biopharma (a platform controlled by KKR), Pictet, Longview Ventures (an affiliate of Broadview Ventures), and Export and Investment […]

Read more